Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RISPERDAL CONSTA vs RITUXIMAB-ABBS: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RISPERDAL CONSTA vs RITUXIMAB-ABBS: Safety Overview

Metric RISPERDAL CONSTA RITUXIMAB-ABBS
Total FAERS Reports 140 4,347
Deaths Reported 29 432
Death Rate 20.7% 9.9%
Hospitalizations 56 1,087
Average Patient Age 45.0 yrs 53.5 yrs
% Female Patients N/A 74.2%
Marketing Status N/A Prescription